Literature DB >> 18208790

Giacomo Castelvetro's salads. Anti-HER2 oncogene nutraceuticals since the 17th century?

R Colomer1, R Lupu, A Papadimitropoulou, L Vellón, A Vázquez-Martín, J Brunet, A Fernández-Gutiérrez, A Segura-Carretero, J A Menéndez.   

Abstract

We are accumulating evidence to suggest that 17(th) century Renaissance foodways -largely based on the old "Mediterranean dietary traditions"- may provide new nutraceutical management strategies against HER2-positive breast cancer disease in the 21st century. Epidemiological and experimental studies begin to support the notion that "The Sacred Law of Salads" (i.e., "raw vegetables... plenty of generous (olive) oil") -originally proposed in 1614 by Giacomo Castelvetro in its book The Fruit, Herbs & Vegetables of Italy- might be considered the first (unintended) example of customised diets for breast cancer prevention based on individual genetic make-up (i.e., nutraceuticals against human breast carcinomas bearing HER2 oncogene amplification/overexpression). First, the so-called salad vegetables dietary pattern (i.e., a high consumption of raw vegetables and olive oil) appears to exert a protective effect mostly confined to the HER2-positive breast cancer subtype, with no significant influence on the occurrence of HER2-negative breast cancers. Second, all the main olive oil constituents (i.e., the omega-9 monounsaturated fatty acid oleic acid and polyphenolic compounds such as the secoiridoid oleuropein or the lignan 1-[+]-acetoxypinoresinol) dramatically reduce HER2 expression and specifically induce apoptotic cell death in cultured HER2- positive breast cancer cells, with marginal effects against HER2-negative cells. Third, an olive oil-rich diet negatively influences experimental mammary tumorigenesis in rats likewise decreasing HER2 expression levels. If early 1600s Castelvetro's salads can be used as dietary protocols capable to protecting women against biologically aggressive HER2-positive breast cancer subtypes is an intriguing prospect that warrants to be evaluated in human pilot studies in the future. Here, at least, we would like to recognise Giacomo Castelvetro as the father of modern nutritional genomics in oncology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18208790     DOI: 10.1007/s12094-008-0151-7

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  33 in total

Review 1.  Mediterranean diet, olive oil and cancer.

Authors:  Ramón Colomer; Javier A Menéndez
Journal:  Clin Transl Oncol       Date:  2006-01       Impact factor: 3.405

Review 2.  Nutrigenomics and nutrigenetics: the 'omics' revolution in nutritional science.

Authors:  Edwin C M Mariman
Journal:  Biotechnol Appl Biochem       Date:  2006-06       Impact factor: 2.431

Review 3.  Cancer and Mediterranean dietary traditions.

Authors:  A Trichopoulou; P Lagiou; H Kuper; D Trichopoulos
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-09       Impact factor: 4.254

4.  Dietary fatty acids regulate the activation status of Her-2/neu (c-erbB-2) oncogene in breast cancer cells.

Authors:  J A Menendez; S Ropero; R Lupu; R Colomer
Journal:  Ann Oncol       Date:  2004-11       Impact factor: 32.976

Review 5.  Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9).

Authors:  Javier A Menendez; Ruth Lupu
Journal:  Curr Pharm Biotechnol       Date:  2006-12       Impact factor: 2.837

6.  Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification.

Authors:  J A Menendez; L Vellon; R Colomer; R Lupu
Journal:  Ann Oncol       Date:  2005-01-10       Impact factor: 32.976

7.  Salad vegetables dietary pattern protects against HER-2-positive breast cancer: a prospective Italian study.

Authors:  Milena Sant; Claudia Allemani; Sabina Sieri; Vittorio Krogh; Sylvie Menard; Elda Tagliabue; Elena Nardini; Andrea Micheli; Paolo Crosignani; Paola Muti; Franco Berrino
Journal:  Int J Cancer       Date:  2007-08-15       Impact factor: 7.396

8.  Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway.

Authors:  Tzong-Der Way; Ming-Ching Kao; Jen-Kun Lin
Journal:  J Biol Chem       Date:  2003-11-05       Impact factor: 5.157

9.  Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms.

Authors:  M H Kraus; N C Popescu; S C Amsbaugh; C R King
Journal:  EMBO J       Date:  1987-03       Impact factor: 11.598

Review 10.  Update on HER-2 as a target for cancer therapy: the ERBB2 promoter and its exploitation for cancer treatment.

Authors:  H C Hurst
Journal:  Breast Cancer Res       Date:  2001-10-01       Impact factor: 6.466

View more
  1 in total

1.  Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agents.

Authors:  Javier A Menendez; Jorge Joven; Gerard Aragonès; Enrique Barrajón-Catalán; Raúl Beltrán-Debón; Isabel Borrás-Linares; Jordi Camps; Bruna Corominas-Faja; Sílvia Cufí; Salvador Fernández-Arroyo; Anabel Garcia-Heredia; Anna Hernández-Aguilera; María Herranz-López; Cecilia Jiménez-Sánchez; Eugeni López-Bonet; Jesús Lozano-Sánchez; Fedra Luciano-Mateo; Begoña Martin-Castillo; Vicente Martin-Paredero; Almudena Pérez-Sánchez; Cristina Oliveras-Ferraros; Marta Riera-Borrull; Esther Rodríguez-Gallego; Rosa Quirantes-Piné; Anna Rull; Laura Tomás-Menor; Alejandro Vazquez-Martin; Carlos Alonso-Villaverde; Vicente Micol; Antonio Segura-Carretero
Journal:  Cell Cycle       Date:  2013-01-31       Impact factor: 4.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.